Meeting Coverage

ASCO Future Focus: Immunotherapy

Future Focus from the American Society of Clinical Oncology

FAK Inhibitor Boosts Anti-PD1 Immunotherapy in Pancreatic Cancer

Jun Gong, MD, says the future is bright for immunotherapy-based combinations

image

Latest ASCO Future Focus: Immunotherapy Meeting Coverage

Can a Simple Beta-Blocker Improve Immunotherapy Responses?

A phase II trial examined propranolol's effect on adrenergic stress in esophageal cancer patients

July 7, 2023
Adopting Immunotherapy in MSI-High/dMMR Colorectal Cancers

Van Karlyle Morris, MD, discusses the success of checkpoint blockade in this population

June 30, 2023
Immunotherapy in Lung Cancer: Current Landscape and Future Directions

"There's going to be more immunotherapy trials coming," says Jorge Nieva, MD

June 23, 2023

Latest Oncology/Hematology Meeting Coverage